Primer on Tumor Immunology and Biological Therapy
of Cancer

October 30, 2008
Westin Gaslamp Quarter Hotel
San Diego, CA

Schedule at a Glance (subject to change)

Thursday, October 30
8:00 am - 8:05 am Welcome and Introductions
8:05 am - 8:50 am Cytokines
Mario Sznol, MD - Yale University School of Medicine
8:50 am - 9:35 am Antibody Therapy of Cancer
Lee M. Nadler, MD - Dana-Farber Cancer Institute
9:35 am - 10:20 am Anti-Angiogenic Therapies
David A. Cheresh, PhD – University of California, San Diego
10:20 am - 10:35 am Break
10:35 am - 11:20 am Mechanisms of Immune-Mediated Tumor Lysis
William J. Murphy, PhD - University of Nevada School of Medicine
11:20 am - 12:05 pm Blocking Anti-T Cell Checkpoints
James Allison, PhD - Memorial Sloan-Kettering Cancer Center
12:05 pm - 1:00 pm Lunch
1:00 pm - 1:45 pm Approach to Identification and Therapeutic Exploitation of Tumor Antigens
Walter J. Urba, MD, PhD - Earle A. Chiles Research Institute
1:45 pm - 2:30 pm T Reg Cells
Speaker TBC
2:30 pm - 3:15 pm Adoptive T Cell Therapy
Phillip D. Greenberg, MD - Fred Hutchison Cancer Research Center & University of Washington
3:15 pm - 3:30 pm Break
3:30 pm - 4:15 pm Immune Monitoring of Cancer Immunotherapy
Michael D. Kalos, PhD - City of Hope Cancer Center
4:15 pm - 5:00 pm Immune Adjuvants
A. Karolina Palucka, MD, PhD - Baylor Institute for Immunology Research